No Record Found
Sector
PharmaceuticalsOpen
₹1,764.5Prev. Close
₹1,764.5Turnover(Lac.)
₹972.88Day's High
₹1,788.3Day's Low
₹1,75852 Week's High
₹1,95252 Week's Low
₹1,385.75Book Value
₹241.02Face Value
₹1Mkt Cap (₹ Cr.)
27,599.89P/E
39.23EPS
44.97Divi. Yield
0.87No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 15.57 | 15.52 | 15.51 | 15.46 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3,361.63 | 2,870.74 | 2,426.98 | 2,088.21 |
Net Worth | 3,377.2 | 2,886.26 | 2,442.49 | 2,103.67 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 2,189.87 | 1,891.99 | 1,640.74 | 1,250.13 |
yoy growth (%) | 15.74 | 15.31 | 31.24 | 6.42 |
Raw materials | -743.69 | -625.75 | -569.13 | -479.67 |
As % of sales | 33.96 | 33.07 | 34.68 | 38.36 |
Employee costs | -399.06 | -305.97 | -293.78 | -217.3 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 471.29 | 593.7 | 349.56 | 179.04 |
Depreciation | -71.28 | -67.35 | -65.09 | -55.94 |
Tax paid | -110.29 | -146.62 | -71.41 | -51.04 |
Working capital | 298.14 | 110.36 | 28.72 | 67.62 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 15.74 | 15.31 | 31.24 | 6.42 |
Op profit growth | -7.84 | 49.09 | 85.51 | -10.11 |
EBIT growth | -20.74 | 70.46 | 93.19 | -17.73 |
Net profit growth | -19.25 | 66.73 | 109.48 | -25.99 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 3,917.99 | 3,484.18 | 3,149.28 | 2,424.24 | 2,042.52 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,917.99 | 3,484.18 | 3,149.28 | 2,424.24 | 2,042.52 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 38.32 | 37.27 | 9.94 | 39.23 | 112.38 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,799.5 | 92.81 | 4,33,763.77 | 564.22 | 0.89 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,417.5 | 67.82 | 1,70,489.23 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,728 | 59.24 | 1,26,435.85 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,516.6 | 23.68 | 1,23,088.18 | 1,210.53 | 1.05 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,275.2 | 19.48 | 1,05,162.27 | 387.3 | 0.63 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive & Independent Director
Sumit Bose
Non-Executive & Non-Independent Director
Prashant Kumar.
Whole Time Director & Chief Executive Officer
Nikhil Chopra
Vice President & Company Secretary
SANDEEP PHADNIS
Chairman & Independent Director
Arun Duggal
Non-Executive & Non-Independent Director
GAURAV TREHAN
Non-Executive & Non-Independent Director
Akshay Tanna
Non Executive & Independent Director
Ashwani Puri
Independent Director
Richa Arora
Neelam Centre 4th Floor,
B-Wing Hind Cycle Road Worli,
Maharashtra - 400030
Tel: 91-022-2482 2222/2493 0918
Website: http://www.jbpharma.com
Email: investorelations@jbpharma.com; secretarial@jbpharm
Plot No B-5 MIDC,
Part B Cross Lane, Marol Andheri(E),
Mumbai-400093
Tel: 91-22-6671 2151
Website: www.dfssl.com
Email: marketing@dfssl.com/investorsqry@dfssl.com
Summary
J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976. The Company is engaged i...
Read More
Reports by J B Chemicals & Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.